Keragen implant

11/01/1986 - "Thus, these results indicate that subdermal injection of Keragen implant can provide significant reduction in the pain and keratoses associated with heloma durum and heloma molle."
11/01/1986 - "The incidence of pain, keratoses, and both pain and keratoses among Keragen implant-treated sites remained significantly lower than among control sites for up to 12 months after treatment. "
11/01/1986 - "In this study, glutaraldehyde cross-linked collagen (Keragen implant) was injected subdermally beneath heloma durum and heloma molle for the relief of both the pain and keratoses associated with these lesions. "
07/01/1988 - "Thus, these results indicate that subdermal injection of Keragen implant collagen can provide significant retardation in the formation of keratosis and reduction in the pain associated with tylomas."
07/01/1988 - "Glutaraldehyde cross-linked collagen, Keragen implant, was injected subdermally beneath tylomas for the relief of both the pain and keratoses associated with these lesions. "

11/01/1986 - "Thus, these results indicate that subdermal injection of Keragen implant can provide significant reduction in the pain and keratoses associated with heloma durum and heloma molle."
11/01/1986 - "The incidence of pain, keratoses, and both pain and keratoses among Keragen implant-treated sites remained significantly lower than among control sites for up to 12 months after treatment. "
11/01/1986 - "In this study, glutaraldehyde cross-linked collagen (Keragen implant) was injected subdermally beneath heloma durum and heloma molle for the relief of both the pain and keratoses associated with these lesions. "
07/01/1988 - "Thus, these results indicate that subdermal injection of Keragen implant collagen can provide significant retardation in the formation of keratosis and reduction in the pain associated with tylomas."
07/01/1988 - "Glutaraldehyde cross-linked collagen, Keragen implant, was injected subdermally beneath tylomas for the relief of both the pain and keratoses associated with these lesions. "

11/01/1987 - "A new injectable biomaterial, Keragen Implant, was evaluated on two patients with bilateral diabetic ulcers. "